These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2071448)

  • 1. PET and plasma pharmacokinetic studies after bolus intravenous administration of [11C]melatonin in humans.
    Le Bars D; Thivolle P; Vitte PA; Bojkowski C; Chazot G; Arendt J; Frackowiak RS; Claustrat B
    Int J Rad Appl Instrum B; 1991; 18(3):357-62. PubMed ID: 2071448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of high-dose intravenous melatonin in humans.
    Andersen LP; Werner MU; Rosenkilde MM; Fenger AQ; Petersen MC; Rosenberg J; Gögenur I
    J Clin Pharmacol; 2016 Mar; 56(3):324-9. PubMed ID: 26184078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 6-hydroxymelatonin, 6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to rats.
    Raynaud F; Mauviard F; Geoffriau M; Claustrat B; Pevet P
    Biol Signals; 1993; 2(6):358-66. PubMed ID: 8038864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.
    Mallo C; Zaĭdan R; Galy G; Vermeulen E; Brun J; Chazot G; Claustrat B
    Eur J Clin Pharmacol; 1990; 38(3):297-301. PubMed ID: 2340850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration.
    Cheung RT; Tipoe GL; Tam S; Ma ES; Zou LY; Chan PS
    J Pineal Res; 2006 Nov; 41(4):337-43. PubMed ID: 17014690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Safety of Intravenous, Intravesical, Rectal, Transdermal, and Vaginal Melatonin in Healthy Female Volunteers: A Cross-Over Study.
    Zetner D; Andersen LPK; Alder R; Jessen ML; Tolstrup A; Rosenberg J
    Pharmacology; 2021; 106(3-4):169-176. PubMed ID: 32937627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.
    Nybäck H; Halldin C; Ahlin A; Curvall M; Eriksson L
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):31-6. PubMed ID: 7862909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the brain uptake properties of [1-11C]labeled hexanoate in anesthetized cats by means of positron emission tomography.
    Sakiyama Y; Ishiwata K; Ishii K; Oda K; Toyama H; Ishii S; Nakayama H; Sato A; Senda M
    Ann Nucl Med; 1996 Aug; 10(3):361-6. PubMed ID: 8883717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and pharmacokinetics of melatonin in the ewe.
    English J; Bojkowski CJ; Poulton AL; Symons AM; Arendt J
    J Pineal Res; 1987; 4(4):351-8. PubMed ID: 3668786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers.
    Ait Abdellah S; Gal C; Guinobert I; Bardot V; Raverot V; Vitacca A; Blondeau C; Claustrat B
    Drugs R D; 2024 Sep; 24(3):415-423. PubMed ID: 39174857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct radioimmunoassay of 6-sulfatoxymelatonin in plasma with use of an iodinated tracer.
    Harthé C; Claustrat B; Brun J; Chazot G
    Clin Chem; 1991 Apr; 37(4):536-9. PubMed ID: 2015667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin pharmacokinetics after transdermal administration changes according to the time of the day.
    Flo A; Cambras T; Díez-Noguera A; Calpena A
    Eur J Pharm Sci; 2017 Jan; 96():164-170. PubMed ID: 27644893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
    Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
    Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of circadian rhythm in the disposition of melatonin in the cow.
    Berthelot X; Ravault JP; Concordet D; Ferney J; Toutain PL
    J Pineal Res; 1993 Oct; 15(3):141-6. PubMed ID: 8106960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers.
    Andersen LP; Werner MU; Rosenkilde MM; Harpsøe NG; Fuglsang H; Rosenberg J; Gögenur I
    BMC Pharmacol Toxicol; 2016 Feb; 17():8. PubMed ID: 26893170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetically guided melatonin scheduling in rats with circadian system suppression.
    Deprés-Brummer P; Metzger G; Morin D; Urien S; Touitou Y; Tillement JP; Claustrat B; Lévi F
    Eur J Pharmacol; 1996 Sep; 312(2):171-8. PubMed ID: 8894592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.